Since its launch in 2017, Atlanta-based digital health IT company has grown rapidly to become one of the largest cancer-focused networks in the country ATLANTA, January 13, 2021-- OncoLens, a pioneer in tumor board and cancer treatment planning solutions, announced today that it has raised a $7.25 million Series A investment from BIP Capital, Martin Ventures, and SeedToB Capital, a new healthcare artificial intelligence (AI) venture fund launched by former Jvion Co-founders Shantanu Nigam and Ritesh Sharma. OncoLens brings collaborative and personalized treatment planning to the cancer patient through data integration and decision support.